Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05108415Unknown

Development and Validation of a Multi-target, Blood-based NAFLD Diagnosis Test

Role: collaborator

NCT05091229Unknown

A Blood Test to Diagnose Kawasaki Disease

Role: collaborator

NCT05115786Unknown

Cohort Study to Evaluate the Relapse Risk Test in Colorectal Cancer

Role: collaborator

NCT05142813Unknown

A Blood Test to Diagnose Sepsis in Symptomatic Adults and Children

Role: lead

All 4 trials loaded